UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000038258
Receipt No. R000043612
Scientific Title A study for efficacy on post-meal stomach discomfort by single intake of test food
Date of disclosure of the study information 2019/10/12
Last modified on 2020/01/30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A study for efficacy on post-meal stomach discomfort by single intake of test food
Acronym A study for efficacy on post-meal stomach discomfort by single intake of test food
Scientific Title A study for efficacy on post-meal stomach discomfort by single intake of test food
Scientific Title:Acronym A study for efficacy on post-meal stomach discomfort by single intake of test food
Region
Japan

Condition
Condition Healthy individuals
Classification by specialty
Not applicable Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effect of improving gastric discomfort after eating the test foods.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes VAS (Fullness, Stomach feeling, appetite, general fatigue, sleepiness, defecation desire)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Single ingestion of study food containing 1500mg Euglena powder
Interventions/Control_2 Single ingestion of study food containing 1500mg Euglena Koji powder
Interventions/Control_3 Single ingestion of control food substance
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
70 years-old >
Gender Male and Female
Key inclusion criteria 1) Healthy men and women whose age at the time of obtaining consent is between 20 and 70
2) Those who have had stomach upset after meal for the past month
3) Those who can visit the medical facility where the test is conducted
4) Those who were not judged to lack consent by the investigator
Key exclusion criteria 1) Serious liver disorder, kidney / heart disease, organ disorder, diabetes, food allergic disease, gastrointestinal disorder, anxiety disorder, depression, sleep disorder, other serious disease, or person with the history
2) Those with a history of surgery for organic diseases (peptic ulcer, gastritis, reflux esophagitis, etc.) and gastrointestinal diseases
3) Person with stomach pain as chief complaint
4) Those who received H.pylori eradication treatment within 6 months
5) Persons with a history of drug dependence or alcohol dependence
6) Persons who are allergic to drugs and food, or who are hypersensitive to the test food (eczema, nausea, diarrhea, etc.)
7) Persons with a history of mental disorders (such as depression)
8) Those who use pharmaceuticals that may affect this study, foods for specified health use, foods with functional claims, supplements, and health foods, and cannot be stopped during the study period
9) Persons who cannot stop taking specified health foods, foods with functional claims, supplements and health foods during the test period
10) Those who continue to use pharmaceuticals (OTC, internal medicines including prescription drugs)
11) Person who drinks over 1,000 mL (40 g in alcohol equivalent) per day of normal beer (5%)
12) Those who are taking warfarin
13) Pregnant and breastfeeding, and those who plan to do so
14) Person who donated blood components or 200 mL of whole blood from the month before the start of the test to the start of the test, or who donated 400 mL or more within 3 months
15) Those who have participated in other clinical trials within one month from the time of obtaining consent, or who are scheduled to participate in other clinical trials
16) Other persons who are deemed inappropriate by the study investigator to participate in this study
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Ayaka
Middle name
Last name Nakashima
Organization euglena Co., Ltd.
Division name Advanced Technology Research Department Functionality Research Section
Zip code 108-0014
Address Shiba 5-29-11 Minato-ku, Toyko 108-0014, Japan
TEL 080-4120-9684
Email nakashima@euglena.jp

Public contact
Name of contact person
1st name Guan
Middle name
Last name Lei
Organization APO PLUS STATION CO., LTD.
Division name CRO Department Food Test Division
Zip code 103-0027
Address 2-14-1, Nihonbashi, Chuo-ku, Tokyo, 103-0027 Japan
TEL 03-6386-8809
Homepage URL
Email l-guan@apoplus.co.jp

Sponsor
Institute APO PLUS STATION CO., LTD.
Institute
Department

Funding Source
Organization euglena Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ageo Central Second Hospital
Address 421-1 ,Jitogata, Ageo-shi, Saitama,Japan
Tel 048-781-1101
Email soumu@ach2.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 医療法人社団愛友会 上尾中央第二病院

Other administrative information
Date of disclosure of the study information
2019 Year 10 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 09 Month 06 Day
Date of IRB
2019 Year 09 Month 20 Day
Anticipated trial start date
2019 Year 10 Month 12 Day
Last follow-up date
2019 Year 10 Month 26 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 10 Month 09 Day
Last modified on
2020 Year 01 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043612

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.